Wall Street snapped a two-week losing streak as headlines about President Donald Trump's remarks on tariff policy, economic data on inflation and corporate earnings took center stage. The S&P ...

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Unlicensed pharmacies purporting to sell pharmaceutical drugs are thriving despite the efforts by the U.S. Drug Enforcement Administration to stop them.

Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its price objective hoisted by research analysts at JPMorgan Chase & Co. from $167.00 to $168.00 in a report released on Thursday,Benzinga ...

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF – Get Free Report) was the recipient of a large drop in short interest in January. As of January 31st, there was short interest totalling 18,300 shares, a ...

HHS Secretary Robert F. Kennedy Jr. said any staffers in the department who are "working for the pharmaceutical industry" ...

A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

A new, generic, non-steroidal anti-inflammatory drug (NSAID) is now available for managing osteoarthritis (OA) pain in horses ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...